Pathway Genomics Stock
Genetic DNA Testing Company
Sign up today and learn more about Pathway Genomics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Pathway Genomics Stock
Pathway Genomics provides a comprehensive set of genomic testing services across the healthcare spectrum, including tests for general health and wellness, liquid biopsy, pharmacogenomics, hereditary cancer risk and carrier screening. Its general health and wellness tests, including PathwayFit®, Cardiac DNA Insight®, and SkinFit™, equip physicians and patients with genetic information to support lifestyle choices. Liquid biopsy tests, including CancerIntercept™ Detect and Monitor, are non-invasive tests for detection of circulating tumor DNA. Pathway’s pharmacogenomics tests (Mental Health DNA Insight® and Pain Medication DNA Insight®) provide genetic information to help guide selection of optimal medication for management of mental health and pain disorders. Pathway’s hereditary cancer risk tests, including BRCATrue® and ColoTrue®, evaluate genetic factors for future cancer risk. Pathway Genomics Corporation operates a clinical laboratory to provide its commercial genetic testing services to physicians and their patients in the United States and internationally. Pathway Genomics Corporation was incorporated in 2008 and is based in San Diego, California.
Investors
IBM Ventures
Welltok, Apttus, Digital Asset, Lightbend, IFTTT, Pathway Genomics
Funding History
July 2009 | $3.0M |
---|---|
January 2016 | $40.0M |
Management
Chief Laboratory Officer & Medical Director
Nilesh Dharajiya, M.D.
Chief Business Officer
K'Lene Oen
Chief Financial Officer
Kamal Adawi
Executive Vice President, Domestic Sales
Anthony Facinelli
Chief Scientific Officer
Anja Kammesheidt, Ph.D.
Vice President of Business Development and Government Relations
Mitch Mulanix
Chief Medical Officer
Glenn D. Braunstein, M.D.
Founder and CEO
James Plante
Chief Privacy and Compliance Officer
Michael H. Cox, CIPP
Chief Innovation Officer
Michael Nova, M.D.
Press
prweb - Jun, 17 2020
Gateway Genomics Announces Partnership with Any Lab Test Now, Increasing Accessibility of the SneakPeek Early Gender DNA Testgenomeweb - Feb, 15 2020
Amid Customer Complaints, Genetic Testing Firm Pathway OME Acquired by OME Wellnessgenomeweb - Feb, 15 2020
Amid Customer Complaints, Genetic Testing Firm Pathway OME Acquired by OME Wellnessmarketwatch - Sep, 30 2019
Genetic Testing Market Forecast 2024 By GeneDx , Invitae , Pathway Genomics , Counsyl Inc , Asper Biotech , GenePlanetprnewswire - Aug, 23 2019
Raken Adds to Executive Team to Bolster Growth Strategy